Product Details for: Conexxence
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Subcutaneous
60MG/ML
Pre-Filled Syringe
351(k) Interchangeable
Conexxence
Rx
002
Injection
Subcutaneous
120MG/1.7ML (70MG/ML)
Single-Dose Vial
351(k) Interchangeable
Bomyntra
Rx
003
Injection
Subcutaneous
120MG/1.7ML (70MG/ML)
Pre-Filled Syringe
351(k) Interchangeable
Bomyntra
Rx
Proper Name
denosumab-bnht
denosumab-bnht
Reference Product Proper Name
denosumab
denosumab
Reference Product Properietary Name
Prolia
Prolia
BLA Number
761398
761398
Applicant
Fresenius Kabi USA, LLC
Fresenius Kabi USA, LLC
Original Approval Date
March 25, 2025
March 25, 2025
Date of First Licensure